Efficacy of Desvenlafaxine 50 mg/d Versus Placebo in the Long-Term Treatment of Major Depressive Disorder: A Randomized, Double-Blind Trial.

Patrice Boyer,Cécile Vialet,Eunhee Hwang,Karen A. Tourian

Efficacy of Desvenlafaxine 50 mg/d Versus Placebo in the Long-Term Treatment of Major Depressive Disorder: A Randomized, Double-Blind Trial.

2015

Patrice Boyer
Cécile Vialet
Eunhee Hwang
Karen A. Tourian

Objective: To examine long-term (11-month) antidepressant efficacy of desvenlafaxine 50 mg/d across a broad range of clinical and functional outcomes in patients with major depressive disorder.

Keywords:

Antidepressant
Psychiatry
Medicine
Placebo
Desvenlafaxine 50 MG
Major depressive disorder
double blind
depressive symptoms
Rating scale
long term treatment
Desvenlafaxine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations